1 September 2024 false No description of principal activity Taxfiler 2024.6 true SC740251business:PrivateLimitedCompanyLtd2024-09-012025-03-31 SC7402512024-08-31 SC7402512024-09-012025-03-31 SC740251business:AuditExemptWithAccountantsReport2024-09-012025-03-31 SC740251business:FilletedAccounts2024-09-012025-03-31 SC7402512025-03-31 SC740251business:Director12024-09-012025-03-31 SC740251business:Director22024-09-012025-03-31 SC740251business:RegisteredOffice2024-09-012025-03-31 SC7402512024-08-31 SC740251core:WithinOneYear2025-03-31 SC740251core:WithinOneYear2024-08-31 SC740251core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 SC740251core:ShareCapitalcore:PreviouslyStatedAmount2024-08-31 SC740251core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 SC740251core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-08-31 SC740251core:PreviouslyStatedAmount2025-03-31 SC740251core:PreviouslyStatedAmount2024-08-31 SC740251business:SmallEntities2024-09-012025-03-31 SC740251countries:Scotland2024-09-012025-03-31 SC740251core:PlantMachinery2024-09-012025-03-31 SC740251core:FurnitureFittings2024-09-012025-03-31 SC740251core:ComputerEquipment2024-09-012025-03-31 SC740251core:PlantMachinery2024-08-31 SC740251core:FurnitureFittings2024-08-31 SC740251core:ComputerEquipment2024-08-31 SC740251core:PlantMachinery2025-03-31 SC740251core:FurnitureFittings2025-03-31 SC740251core:ComputerEquipment2025-03-31 SC7402512023-09-012024-08-31 iso4217:GBP xbrli:pure
Company Registration No. SC740251 (Scotland)
Oushk Pharmacy Ltd Unaudited accounts for the period from 1 September 2024 to 31 March 2025
Oushk Pharmacy Ltd Unaudited accounts Contents
Page
- 2 -
Oushk Pharmacy Ltd Company Information for the period from 1 September 2024 to 31 March 2025
Directors
Bilal Hussain Hira Malik
Company Number
SC740251 (Scotland)
Registered Office
58 Long Lane Broughty Ferry Dundee DD5 1HH Scotland
Accountants
Shipleys Tax - Chartered Accountants 32 Park Cross Street Leeds West Yorkshire LS1 2QH
- 3 -
Oushk Pharmacy Ltd Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
6,178 
4,518 
Current assets
Inventories
100,000 
- 
Debtors
1,244,278 
228,238 
Cash at bank and in hand
415,459 
17,831 
1,759,737 
246,069 
Creditors: amounts falling due within one year
(915,529)
(125,662)
Net current assets
844,208 
120,407 
Net assets
850,386 
124,925 
Capital and reserves
Called up share capital
2 
2 
Profit and loss account
850,384 
124,923 
Shareholders' funds
850,386 
124,925 
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 9 April 2025 and were signed on its behalf by
Bilal Hussain Director Company Registration No. SC740251
- 4 -
Oushk Pharmacy Ltd Notes to the Accounts for the period from 1 September 2024 to 31 March 2025
1
Statutory information
Oushk Pharmacy Ltd is a private company, limited by shares, registered in Scotland, registration number SC740251. The registered office is 58 Long Lane, Broughty Ferry, Dundee, DD5 1HH, Scotland.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
5 Years
Fixtures & fittings
5 Years
Computer equipment
3 Years
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
- 5 -
Oushk Pharmacy Ltd Notes to the Accounts for the period from 1 September 2024 to 31 March 2025
Going concern
The accounts have been prepared on the going concern basis due to the continued support of the director, and principle creditor, Mr B Hussain.
Judgments in applying accounting policies and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
4
Tangible fixed assets
Plant & machinery 
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At 1 September 2024
843 
166 
3,995 
5,004 
Additions
441 
- 
2,559 
3,000 
At 31 March 2025
1,284 
166 
6,554 
8,004 
Depreciation
At 1 September 2024
27 
1 
458 
486 
Charge for the period
147 
19 
1,174 
1,340 
At 31 March 2025
174 
20 
1,632 
1,826 
Net book value
At 31 March 2025
1,110 
146 
4,922 
6,178 
At 31 August 2024
816 
165 
3,537 
4,518 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
266,788 
115,802 
Trade debtors
502,628 
97,856 
Amounts due from group undertakings etc.
456,358 
- 
Accrued income and prepayments
6,338 
- 
Other debtors
12,166 
14,580 
1,244,278 
228,238 
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
133,999 
11,297 
Amounts owed to group undertakings and other participating interests
- 
2,777 
Taxes and social security
287,435 
40,572 
Loans from directors
57 
- 
Accruals
494,038 
71,016 
915,529 
125,662 
- 6 -
Oushk Pharmacy Ltd Notes to the Accounts for the period from 1 September 2024 to 31 March 2025
7
Transactions with related parties
During the financial year ended 31 March 2025, the company incurred royalty payments to its parent company, Oushk Ltd, for the right to use the trademarked name "Oushk". The total amount of royalty payments made during the year was £423,022 (2024:£71,016), recorded within cost of sales in the profit and loss account. These transactions were conducted at arm’s length and on normal commercial terms. The outstanding balance payable to the parent company as at of 31 March 2025 is included within liabilities.
8
Controlling party
As at the balance sheet date, the ultimate controlling party of Oushk Pharmacy Ltd is Oushk Ltd, a company incorporated in England & Wales. Oushk Ltd holds 100% of the issued share capital of Oushk Pharmacy Ltd, giving it the ability to exercise control over the company.
9
Average number of employees
During the period the average number of employees was 3 (2024: 1).
- 7 -